Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
详细信息 查看全文
- 作者：Ibrahim Aldoss1 ; Ni-Chun Tsai2 ; Marilyn L. Slovak3 ; Joycelynne Palmer2 ; Joseph Alvarnas1 ; Guido Marcucci1 ; Stephen J. Forman1 ; Vinod Pullarkat1 ; vpullarkat@coh.org" class="auth_mail" title="E-mail the corresponding author
- 关键词：Acute lymphoblastic leukemia ; Adult ; Cytogenetics ; Allogeneic ; Hematopoietic cell transplantation ; Survival
- 刊名：Biology of Blood and Marrow Transplantation
- 出版年：2016
- 出版时间：July 2016
- 年：2016
- 卷：22
- 期：7
- 页码：1212-1217
- 全文大小：753 K
文摘
- •
Cytogenetic risk is not an independent predictor of outcomes in alloHCT for adult ALL.
- •
Tacrolimus/sirolimus–based prophylaxis is associated with favorable NRM after alloHCT for adult ALL.